Tissue-engineered grafts composed of adult stem cells could 1 day replace synthetic vascular bypass grafts

Apr 08, 2010

Using adult stem cells, researchers have created functional blood vessels that could one day replace synthetic grafts often required in various vascular bypass surgeries, according to research presented at the American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology Annual Conference 2010.

Bypass surgery is used to open blocked arteries in one part of the body by using a vessel from elsewhere in the body. However, up to 40 percent of patients don't have a vessel suitable for the procedure. In such cases, surgeons use synthetic grafts. But the artificial blood vessels often become clogged within one to three years at a higher rate than natural arteries often leading to serious infections.

"Our grafts have the potential to be used for peripheral artery disease bypass (mostly in the legs), and arteriovenous fistula (a type of vascular access for ), and ," said Stephen E. McIlhenny, Ph.D., lead author of the study and tissue engineer of Thomas Jefferson University Hospital in Philadelphia. "However, the first uses of the grafts would be for treatment of and dialysis access grafting."

McIlhenny and colleagues reported encouraging results from their first pre-clinical tests of the graphs.

"It was our idea to create a more biological conduit that would avoid the problems of synthetic grafts and give patients a better alternative," said McIlhenny. "The significant finding is that we can build a blood vessel from donor tissue and an animal's own adult stem cells. Potentially, patients requiring bypass surgery could receive optimized grafts that would reduce their future complications."

Researchers grew rabbit adult stem cells on human vein scaffolds in the laboratory. The team removed all cells from sections of human saphenous veins, which left a tube consisting only of the protein scaffolding that supported the cells. Because the scaffolding contains no cells; there is less risk the immune system will reject it.

The researchers derived from the fat cells of each rabbit that would receive the test graft. They grew the stem cells on pieces of scaffolding, and each rabbit received a graft with only its own stem cells on it.

"Fat cells are easily obtained with liposuction," McIlhenny said. "Bone-marrow-derived stem cells require going into the bone canal to take bone marrow out, which can be painful."

Surgeons cut the abdominal aorta of five male rabbits and inserted stem cell grafts into the large artery. In five other male rabbits, they similarly inserted grafts of the bare protein scaffolding. They examined the animals every two weeks for eight weeks with ultrasound, monitoring whether their inserted grafts were closing up.

After eight weeks, surgeons removed the grafts from the 10 animals. The five bare scaffolding grafts showed significant thickening akin to that seen in human cardiovascular disease, as well as evidence of blood clots.

As for the other five grafts, "we found that using the stem cells as a coating prevented clotting and thickening of the graft wall," McIlhenny said. "I would say those grafts were significantly better."

Considerably more work remains, including additional animal testing, before studies of the fat-cell-derived grafts can begin in human testing. The team is attempting to grow smooth muscle cells on the outer layer of the scaffolding. In arteries, this layer of cells strengthens the blood vessels and enables them to contract.

The group is also investigating a suspected but unproven function of nitric oxide in the success of the adult stem cell graft. Nitric oxide is known to inhibit platelet aggregation and blood-clot formation in blood vessels. "We are going to attempt to prove more definitely that this molecule is protecting our graft against wall thickening," McIlhenny said.

Explore further: Were clinical trial practices in East Germany questionable?

add to favorites email to friend print save as pdf

Related Stories

Researchers characterize stem cell function

Mar 11, 2010

The promise of stem cells lies in their unique ability to differentiate into a multitude of different types of cells. But in order to determine how to use stem cells for new therapeutics, scientists and engineers need to ...

Engineered Blood Vessels Function like Native Tissue

Jul 05, 2007

Blood vessels that have been tissue-engineered from bone marrow adult stem cells may in the future serve as a patient's own source of new blood vessels following a coronary bypass or other procedures that require vessel replacement, ...

Body's own veins provide superior material for aortic grafts

Dec 30, 2009

A vascular surgical technique pioneered at UT Southwestern Medical Center and designed to replace infected aortic grafts with the body's own veins has proved more durable and less prone to new infection than similar procedures ...

Recommended for you

Were clinical trial practices in East Germany questionable?

Oct 23, 2014

Clinical trials carried out in the former East Germany in the second half of the 20th century were not always with the full knowledge or understanding of participants with some questionable practices taking place, according ...

Schumacher's doctor sees progress after injury

Oct 23, 2014

A French physician who treated Michael Schumacher for nearly six months after the Formula One champion struck his head in a ski accident says he is no longer in a coma and predicted a possible recovery within three years.

User comments : 0